Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Shares Outstanding (Weighted Average): 2009-2020

Historic Shares Outstanding (Weighted Average) for Neurocrine Biosciences (NBIX) over the last 12 years, with Dec 2020 value amounting to $93.4 million.

  • Neurocrine Biosciences' Shares Outstanding (Weighted Average) rose 1.49% to $94.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $94.6 million, marking a year-over-year increase of 1.49%. This contributed to the annual value of $93.4 million for FY2020, which is 1.45% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Shares Outstanding (Weighted Average) stood at $93.4 million for FY2020, which was up 1.45% from $92.1 million recorded in FY2019.
  • Neurocrine Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $93.4 million for FY2020, and its period low was $86.9 million during FY2016.
  • For the 3-year period, Neurocrine Biosciences' Shares Outstanding (Weighted Average) averaged around $92.1 million, with its median value being $92.1 million (2019).
  • Data for Neurocrine Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 2.47% (in 2018) over the last 5 years.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Shares Outstanding (Weighted Average) stood at $86.9 million in 2016, then grew by 1.87% to $88.5 million in 2017, then grew by 2.47% to $90.7 million in 2018, then grew by 1.56% to $92.1 million in 2019, then climbed by 1.45% to $93.4 million in 2020.